Serology – CLIA
Assays are intended to be used in combination only with the fully automated Random Access platform S.A.R.A.
Chemi-Luminescence ImmunoAssay (CLIA) for the semi-quantitative determination of total antibodies (IgG&A&M) to Plasmodium species (Malaria) in human plasma and sera. The kit is intended for the screening of anti Malaria antibodies in blood units and the follow-up of infected patients. The devise does not type antibodies into IgG&A&M but detects the totality of them. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.
Chemi-Luminescence ImmunoAssay (CLIA) for the semi-quantitative determination of total antibodies (IgG&A&M) to Hepatitis E Virus (HEV) in human plasma and sera. The kit is intended for the follow-up of HEV infected patients. The devise does not type antibodies into IgG&A&M but detects the totality of them. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.
Chemi-Luminescence ImmunoAssay (CLIA) for the determination of antibodies to Hepatitis D Virus in human plasma and sera. . The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.
Chemi-Luminescence ImmunoAssay (CLIA) for the quantitative determination of IgG antibodies to Tetanus Toxoid in human plasma and sera. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.